PCSK9 and metabolic dysfunction-associated steatotic liver disease: Furthermore, PCSK9i demonstrated utility as a treatment for both disorders, increasing the clearance of LDL from the circulation and improving NAFLD symptoms whilst decreasing the higher-than-normal levels of PCSK9 in patients with PCOS.